semaglutide and sjogren's Novartis Presents Positive Phase III NEPTUNUS-1 NEPTUNUS-2 Trial Results for Ianalumab in Sjögren's Disease Frontiers | Biomarkers and Diagnostic
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28




























